We observed a generally low frequency of amplification and deletion in m7G writer genes across 33 cancer types (<10%) (Figures 1B and S1; Table S2), apart from METTL1, which showed amplification across various cancer types, particularly in SARC and GBM (~15%) (Figure 1B,C). This evidence concerns the gene METTL1 and cancer.